arrow
Y

Yvonne M. Saenger

Yeshiva University
H指数:31
被引数:4,402

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathomic immune biomarkers define recurrence risk in early-stage melanoma

病理免疫生物标志物定义早期黑色素瘤的复发风险

2025-10-010
OAAI
Combining immunotherapy with high-dose radiation therapy (HDRT) significantly inhibits tumor growth in a syngeneic mouse model of high-risk neuroblastoma

免疫疗法与高剂量放射疗法 (HDRT) 相结合可显着抑制高风险神经母细胞瘤的同系小鼠模型中的肿瘤生长

HELIYON
IF3.6
2023-06-014
OAAI
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study
2022-08-1211
OAAI
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
2022-05-0510
OA
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma

自动数字TIL分析 (ADTA) 为原发性黑色素瘤的深度和溃疡的标准评估增加了预后价值

2021-02-0223
OAAI
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
2020-06-1619
OAAI
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma
2020-03-0217
OAAI